Evidence map›Paper›PMID 30105776›Full record

ArticleJournal of medical radiation sciences2018

Dosimetric comparison of surface mould HDR brachytherapy with VMAT.

Eeva L Boman, Dean B Paterson, Shelley Pearson, Nichola Naidoo, Carol Johnson

Open access · goldAbstract readComparative Study
In one paragraph

Article in Journal of medical radiation sciences, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. The value of brachytherapy in the age of advanced external beam radiotherapy: a review of the literature in terms of dosimetry.Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] · 2022
    Review
  4. Validation of an individualized home-made superficial brachytherapy mold applied for deep nonmelanoma skin cancer.Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology · 2022
    Article
  5. Article
  6. Article
  7. Dosimetric comparison of surface mould HDR brachytherapy with VMAT.Journal of medical radiation sciences · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 2 countries.

Eeva L BomanBlood & Cancer Centre, Wellington Hospital, Wellington, New Zealand.ORCID http://orcid.org/0000-0001-6492-2475
Dean B PatersonBlood & Cancer Centre, Wellington Hospital, Wellington, New Zealand.
Shelley PearsonBlood & Cancer Centre, Wellington Hospital, Wellington, New Zealand.
Nichola NaidooBlood & Cancer Centre, Wellington Hospital, Wellington, New Zealand.
Carol JohnsonBlood & Cancer Centre, Wellington Hospital, Wellington, New Zealand.
Wellington Hospital · NZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThe aim of this study was to investigate the dosimetric differences between surface mould high-dose-rate (HDR) brachytherapy and external beam volumetric-modulated arc therapy (VMAT) for two treatment sites.

methodsPreviously treated HDR brachytherapy surface mould scalp (n = 4) and lower leg (n = 3) treatments were retrospectively analysed. The VMAT plans were optimised using an additional 3-mm setup margin on the clinical target volume (CTV) of the previously treated HDR plans. The HDR plans were calculated and normalised using the TG-43 formalism and recalculated with Acuros BV (AC).

resultsOn average, the mean brain and normal tissue doses were reduced by 44.8% and 27.4% for scalp and lower leg VMAT cases, respectively, when compared to AC calculated HDR plans. For VMAT plans, the average dose to a 1-mm thick skin structure deep to the target volume was not any lower than that in AC HDR plans. On average, the CTV coverage was 13.8% and 9.6% lower for scalp cases with AC dose calculation than with TG-43 and 8.3% and 5.3% lower for lower leg cases if 0- or 1-cm backscatter material was applied above the catheters, respectively.

conclusionsVMAT is a feasible treatment option in the case of extensive skin malignancies of the scalp and lower leg. Uncertainties related to delivered dose with HDR brachytherapy when using the TG-43 dose calculation model or possible air gaps between the mould and skin favour the use of VMAT. The potential soft tissue deformation needs to be considered if VMAT is used.

Indexed as

BrachytherapyRadiation DosageRadiotherapy, Intensity-ModulatedHumansLower ExtremityRadiometryRadiotherapy DosageScalpBrachytherapyFreiburg FlapIntensity-modulated radiation therapyscalpskinvolumetric-modulated arc therapy

Identifiers

PMID30105776
PMCPMC6275250
OpenAlexW2885247341

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.